Alnylam Human Genetics
December 8, 2025
The Future of Medicine is in Our Genes
Additional human genetics data partnerships are helping scientists identify new drug targets, improving the chances of developing effective medicines
Read More ›
March 16, 2023
Alnylam's Paul Nioi, PhD on The Genetics Podcast: Using Genetics in Drug Target Discovery
Paul Nioi, PhD, VP of Discovery and Translational Research and Head of Alnylam Human Genetics recently spoke with Dr. Patrick Short on The Genetics Podcast.
Read More ›
March 10, 2023
Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics
Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics
Read More ›
January 18, 2018
Alnylam Co-Founds UK Biobank Exome Sequencing Consortium (UKB-ESC)
Alnylam and partners announced an agreement with the UK Biobank to form the UK Biobank Exome Sequencing Consortium (UKB-ESC), to sequence all 500,000 exomes...
Read More ›
FOLLOW US
